CPDA-1 (Anticoagulant Citrate Phosphate Dextrose Adenine)
**Product type:** Human Prescription Drug
**Active ingredient:** ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE
**Strength:** 19.3; 209; 2.23; 155; 1.84 mg/70mL; mg/70mL; g/70mL; mg/70mL; g/70mL
**Dosage form:** Solution
**Route:** Intravenous
**Labeler:** Fenwal, Inc.
**Marketing category:** NDA (BN770420)
**Pharmacologic class:** Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]
/api/v1/systems/ndc_fda/nodes/0942-6326Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.